# Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer

> **NCT00262821** · PHASE3 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 402 (actual)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Cell Carcinoma
- Cervical Squamous Cell Carcinoma
- Stage IB Cervical Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage IVA Cervical Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** tirapazamine

## Key facts

- **NCT ID:** NCT00262821
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 402 (ACTUAL)
- **Why stopped:** Study drug no longer available resulting in lack of study drug for participants.
- **Last updated:** 2019-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262821, "Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00262821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*